PA
CNI icon

PharVision Advisers’s Canadian National Railway CNI Stock Holding History

PharVision Advisers’s Portfolio CNI Stock Details CNI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-2,219
Closed -$219K – 216
2025
Q4 		$219K Buy
+2,219
New +$213K 0.11% 485

Other funds holding CNI

Gates Foundation Trust
Gates Foundation Trust Kirkland, Washington $34.4B AUM 26.34% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Caisse de Depot et Placement du Quebec (CDPQ)
Caisse de Depot et Placement du Quebec (CDPQ) Montreal, Quebec, Canada $70.2B AUM 30.95% 1-Year Est. Return
1832 Asset Management
1832 Asset Management Toronto, Ontario, Canada $199B AUM 37.98% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $304B AUM 35.64% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

PharVision Advisers's CNI Position: Q1 2026 in Review

PharVision Advisers sold out of Canadian National Railway (CNI) in Q1 2026, closing a stake of 2,219 shares — an estimated $219K sold.

PharVision Advisers first reported a position in CNI in Q4 2025 and held it in 1 quarter. The position peaked at $219K in Q4 2025. 830 funds tracked by Wall St. Rank hold CNI as of Q1 2026.

  • PharVision Advisers reported no remaining Canadian National Railway position as of Q1 2026 after selling out during the quarter.
  • PharVision Advisers sold 2,219 Canadian National Railway shares in Q1 2026, an estimated $219K.
  • PharVision Advisers first reported a position in Canadian National Railway in Q4 2025 and held it in 1 quarter.
  • PharVision Advisers's Canadian National Railway position peaked at $219K in Q4 2025.
  • 830 funds tracked by Wall St. Rank held Canadian National Railway as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.